New therapy for targeting pathogen-dependent immune subversion mechanisms for Leishmaniasis treatment. - Texts

Home
Main Navigation
Content
Search
Help

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

43914.1 IP-LS

Project title

New therapy for targeting pathogen-dependent immune subversion mechanisms for Leishmaniasis treatment.

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Inserted texts

Category	Text
Short description (German)	New therapy for targeting pathogen-dependent immune subversion mechanisms for Leishmaniasis treatment.
Short description (English)	New therapy for targeting pathogen-dependent immune subversion mechanisms for Leishmaniasis treatment.
Abstract (German)	The goal of the project is to demonstrate that the immunostimulating ACB-betacarboline molecules be used to overcome parasite-elicited immune subversion to treat Leishmaniasis in experimental models either alone or combined with anti-leishmanials or anti-PD1 checkpoint inhibitors.